We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Growth Factor May Prevent Stroke

By HospiMedica staff writers
Posted on 16 Jul 2003
A study has shown that injections of a growth factor into rat brains expanded blood vessels and improved blood flow, which may lead to a noninvasive way to prevent stroke. More...
The findings were reported in the July 1, 2003, online issue of Circulation.

Researchers tried to induce arteriogenesis in rat brains by transforming collateral arteries that were unused and located away from the blockage into functioning blood-carrying vessels capable of taking over for the blocked vessels. They induced obstructions in the arteries that reduced blood flow and then injected them with granulocyte macrophage-colony stimulating factor (GM-CSF). Treatment continued for seven or 21 days, while a second group of rats received only saline.

In saline-treated rats, the diameter of the posterior cerebral artery (PCA) increased by 39% during the three weeks. In rats treated with GM-CSF, the artery increased by 72% at the end of only one week. The arteriogenesis was associated with other evidence of improved blood flow, such as the ability to increase flow in response to carbon dioxide and accumulation of macrophages.

"To the best of our knowledge, this is the first report of stimulation of arteriogenesis in the brain,” said co-lead authors Ivo R. Buschmann, M.D., and Hans-Jorg Busch, M.D. Both are investigators in the Research Group for Experimental and Clinical Arteriogenesis at Albert Ludwigs University of Freiburg (Freiburg, Germany).





Related Links:
Univ. of Freiburg

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.